SMITH & NEPHEW PLC

SN.
Delayed London Stock Exchange - 11:35 2022-11-30 am EST
1085.50 GBX +0.70%

Smith+Nephew First to Market with Revision Knee Indication on Robotics Platform

09/26/2022 | 08:00am

Smith+Nephew announces the first cases for revision knee replacement utilizing its CORI? Surgical System. Dr. Thorsten Seyler of Duke University performed the first cases on August 17, 2022, combining Smith+Nephew's handheld robotics technology with its LEGION?

Revision Knee System. Smith+Nephew is the first orthopaedics company to receive FDA 510(k) clearance for a revision indication using a robotics-assisted platform. RI.KNEE ROBOTICS utilizes image-free smart mapping, eliminating the need for pre-operative CT/MRI scans and the potential for image distortion due to in situ components from the primary procedure.

Instead, surgeons are able to build patient-specific 3D models of the joint, register anatomy and bony defects after implant extraction, intra-operatively gap balance in real-time, and accurately precision mill for final placement of components. Surgeons can now experience the power and versatility of one robotics platform when using the CORI Surgical System. With broader capabilities and expanded indications, it can address robotic-assisted total, partial, and now revision knee arthroplasty, along with computer-guided total hip arthroplasty.

By coupling robotics with Smith+Nephew's clinically-proven LEGION RK System with OXINIUM? Technology, surgeons can experience a truly comprehensive implant and technology portfolio. Over the last six months, Smith+Nephew has launched RI.HIP NAVIGATION, RI.HIP MODELER, "Cementless" CONCELOC?

Advanced Porous Titanium 3D printing technology with LEGION? CONCELOC Cementless Total Knee System, and now a revision knee indication. All are supported by the CORI?

Surgical System.

S&P Capital IQ 2022
Copier lien
All news about SMITH & NEPHEW PLC
2d ago
2d ago
2d ago
2d ago
2d ago